BACKGROUND AND OBJECTIVES: It is unclear if hemodiafiltration leads to a better quality of life compared with hemodialysis. It was, therefore, the aim of this study to assess the effect of hemodiafiltration on quality of life compared with hemodialysis in patients with ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study analyzed the data of 714 patients with a median follow-up of 2 years from the Convective Transport Study. The patients were enrolled between June of 2004 and December of 2009. The Convective Transport Study is a randomized controlled trial on the effect of online hemodiafiltration versus low-flux hemodialysis on all-cause mortality. Quality of life was assessed with the Kidney Disease Quality of Life-Short Form. This questionnaire provides data for a physical and mental composite score and describes kidney disease-specific quality of life in 12 domains. The domains have scales from 0 to 100. RESULTS: There were no significant differences in changes in health-related quality of life over time between patients treated with hemodialysis (n=358) or hemodiafiltration (n=356). The quality of life domain patient satisfaction declined over time in both dialysis modalities (hemodialysis: -2.5/yr, -3.4 to -1.5, P<0.001; hemodiafiltration: -1.4/yr, -2.4 to -0.5, P=0.004). CONCLUSIONS: Compared with hemodialysis, hemodiafiltration had no significant effect on quality of life over time.
RCT Entities:
BACKGROUND AND OBJECTIVES: It is unclear if hemodiafiltration leads to a better quality of life compared with hemodialysis. It was, therefore, the aim of this study to assess the effect of hemodiafiltration on quality of life compared with hemodialysis in patients with ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study analyzed the data of 714 patients with a median follow-up of 2 years from the Convective Transport Study. The patients were enrolled between June of 2004 and December of 2009. The Convective Transport Study is a randomized controlled trial on the effect of online hemodiafiltration versus low-flux hemodialysis on all-cause mortality. Quality of life was assessed with the Kidney Disease Quality of Life-Short Form. This questionnaire provides data for a physical and mental composite score and describes kidney disease-specific quality of life in 12 domains. The domains have scales from 0 to 100. RESULTS: There were no significant differences in changes in health-related quality of life over time between patients treated with hemodialysis (n=358) or hemodiafiltration (n=356). The quality of life domain patient satisfaction declined over time in both dialysis modalities (hemodialysis: -2.5/yr, -3.4 to -1.5, P<0.001; hemodiafiltration: -1.4/yr, -2.4 to -0.5, P=0.004). CONCLUSIONS: Compared with hemodialysis, hemodiafiltration had no significant effect on quality of life over time.
Authors: Denis Fouque; Marianne Vennegoor; Piet ter Wee; Christoph Wanner; Ali Basci; Bernard Canaud; Patrick Haage; Klaus Konner; Jeroen Kooman; Alejandro Martin-Malo; Lucianu Pedrini; Francesco Pizzarelli; James Tattersall; Jan Tordoir; Raymond Vanholder Journal: Nephrol Dial Transplant Date: 2007-05 Impact factor: 5.992
Authors: B Canaud; J L Bragg-Gresham; M R Marshall; S Desmeules; B W Gillespie; T Depner; P Klassen; F K Port Journal: Kidney Int Date: 2006-06 Impact factor: 10.612
Authors: Kristina L Allen; Dana Miskulin; Guofen Yan; Johanna T Dwyer; Anne Frydrych; June Leung; Diane Poole Journal: J Ren Nutr Date: 2002-07 Impact factor: 3.655
Authors: Antonio Alberto Lopes; Jennifer L Bragg-Gresham; David A Goodkin; Shunichi Fukuhara; Donna L Mapes; Eric W Young; Brenda W Gillespie; Tadao Akizawa; Roger N Greenwood; Vittorio E Andreucci; Takashi Akiba; Philip J Held; Friedrich K Port Journal: Qual Life Res Date: 2007-02-08 Impact factor: 4.147
Authors: Donna L Mapes; Antonio Alberto Lopes; Sudtida Satayathum; Keith P McCullough; David A Goodkin; Francesco Locatelli; Shunichi Fukuhara; Eric W Young; Kiyoshi Kurokawa; Akira Saito; Jürgen Bommer; Robert A Wolfe; Philip J Held; Friedrich K Port Journal: Kidney Int Date: 2003-07 Impact factor: 10.612
Authors: E Lars Penne; Peter J Blankestijn; Michiel L Bots; Marinus A van den Dorpel; Muriel P Grooteman; Menso J Nubé; Ingeborg van der Tweel; Piet M Ter Wee Journal: Curr Control Trials Cardiovasc Med Date: 2005-05-20
Authors: Alexandra Moura; José Madureira; Pablo Alija; João Carlos Fernandes; José Gerardo Oliveira; Martin Lopez; Madalena Filgueiras; Leonilde Amado; Maria Sameiro-Faria; Vasco Miranda; Alice Santos-Silva; Elísio Costa Journal: Aging Dis Date: 2014-05-25 Impact factor: 6.745
Authors: Julia M T Colombijn; Anna A Bonenkamp; Anita van Eck van der Sluijs; Joost A Bijlsma; Arnold H Boonstra; Akin Özyilmaz; Alferso C Abrahams; Brigit C van Jaarsveld Journal: Am J Nephrol Date: 2021-09-10 Impact factor: 3.754
Authors: I N van Loon; M L Bots; F T J Boereboom; M P C Grooteman; P J Blankestijn; M A van den Dorpel; M J Nubé; P M Ter Wee; M C Verhaar; M E Hamaker Journal: BMC Nephrol Date: 2017-07-06 Impact factor: 2.388